Cargando…
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice
OBJECTIVE: Type 1 diabetes is characterized by autoimmune destruction of β-cells leading to severe insulin deficiency. Although many improvements have been made in recent years, exogenous insulin therapy is still imperfect; new therapeutic approaches, focusing on preserving/expanding β-cell mass and...
Autores principales: | Mallol, Cristina, Casana, Estefania, Jimenez, Veronica, Casellas, Alba, Haurigot, Virginia, Jambrina, Claudia, Sacristan, Victor, Morró, Meritxell, Agudo, Judith, Vilà, Laia, Bosch, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485311/ https://www.ncbi.nlm.nih.gov/pubmed/28702323 http://dx.doi.org/10.1016/j.molmet.2017.05.007 |
Ejemplares similares
-
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
por: Casana, Estefania, et al.
Publicado: (2022) -
Vitamin D Receptor Overexpression in β-Cells Ameliorates Diabetes in Mice
por: Morró, Meritxell, et al.
Publicado: (2020) -
AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance
por: Vilà, Laia, et al.
Publicado: (2016) -
FGF21 gene therapy as treatment for obesity and insulin resistance
por: Jimenez, Veronica, et al.
Publicado: (2018) -
Nonviral-Mediated Hepatic Expression of IGF-I Increases Treg Levels and Suppresses Autoimmune Diabetes in Mice
por: Anguela, Xavier M., et al.
Publicado: (2013)